A share price of Sarepta Therapeutics Inc [SRPT] is currently trading at $130.50, up 13.82%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SRPT shares have gain 22.40% over the last week, with a monthly amount glided 0.18%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Sarepta Therapeutics Inc [NASDAQ: SRPT] stock has seen the most recent analyst activity on November 25, 2024, when H.C. Wainwright initiated its Sell rating and assigned the stock a price target of $80. Previously, Cantor Fitzgerald upgraded its rating to Overweight on November 07, 2024, and elevated its price target to $167. On October 21, 2024, Jefferies initiated with a Buy rating and assigned a price target of $165 on the stock. RBC Capital Mkts upgraded its rating to a Outperform but $182 remained the price target by the analyst firm on July 29, 2024. Citigroup downgraded its rating to Neutral for this stock on June 26, 2024, and upped its price target to $176. In a note dated May 31, 2024, Piper Sandler initiated an Overweight rating and provided a target price of $157 on this stock.
Sarepta Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $78.67 and $173.25. Currently, Wall Street analysts expect the stock to reach $169.06 within the next 12 months. Sarepta Therapeutics Inc [NASDAQ: SRPT] shares were valued at $130.50 at the most recent close of the market. An investor can expect a potential return of 29.55% based on the average SRPT price forecast.
Analyzing the SRPT fundamentals
Trailing Twelve Months sales for Sarepta Therapeutics Inc [NASDAQ:SRPT] were 1.64B which represents 40.79% growth. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.07%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.12 and Total Capital is 0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 120.50 points at the first support level, and at 110.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 135.75, and for the 2nd resistance point, it is at 141.00.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sarepta Therapeutics Inc [NASDAQ:SRPT] is 3.84. Further, the Quick Ratio stands at 3.03, while the Cash Ratio is 0.28. Considering the valuation of this stock, the price to sales ratio is 7.60, the price to book ratio is 10.21 and price to earnings (TTM) ratio is 108.41.
Transactions by insiders
Recent insider trading involved Estepan Ian Michael, Chief Financial Officer, that happened on Aug 30 ’24 when 5985.0 shares were sold. Officer, Estepan Ian Michael completed a deal on Aug 30 ’24 to buy 5985.0 shares. Meanwhile, Director Chambers Michael Andrew bought 37038.0 shares on Aug 16 ’24.
